This topic contains a solution. Click here to go to the answer

Author Question: When planning care for a patient who is receiving filgrastim (Neupogen) for a nonmyeloid malignancy, ... (Read 72 times)

sheilaspns

  • Hero Member
  • *****
  • Posts: 567
When planning care for a patient who is receiving filgrastim (Neupogen) for a nonmyeloid malignancy, the nurse should formulate which of the following patient outcomes? (Select all that apply.)
 
  A) The patient will not develop an infection.
  B) The patient will not experience bone pain.
  C) The patient will be able to self-administer filgrastim at home.
  D) The patient will not develop febrile neutropenia.
  E) The patient will not retain fluid.

Question 2

A 3-month-old infant has been diagnosed with respiratory syncytial virus (RSV) and will begin treatment with inhaled ribavirin. Which of the following measures should be taken in the care of this patient and administration of ribavirin?
 
  A) Serial sputum samples should be obtained daily for the duration of treatment.
  B) Pulmonary function testing should be performed immediately before and 30 minutes after each dose of the drug.
  C) Nurses who are pregnant or who may be pregnant should not administer the drug.
  D) The drug should be administered by a physician or a nurse practitioner.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kescobar@64

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

D

Answer to Question 2

C




sheilaspns

  • Member
  • Posts: 567
Reply 2 on: Jul 23, 2018
:D TYSM


lkanara2

  • Member
  • Posts: 329
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

For a complete list of videos, visit our video library